0.80%| Prev Close: | 13.77 |
|---|---|
| Open: | 13.44 |
| Bid: | 13.18 x 2000 |
| Ask: | N/A |
| 1y Target Est: | 17.00 |
| Beta: | 0 |
| Next Earnings Date: | N/A |
| Day's Range: | 13.44 - 13.78 |
|---|---|
| 52wk Range: | 9.19 - 16.95 |
| Volume: | 28,280 |
| Avg Vol (3m): | 121,859 |
| Market Cap: | 500.40M |
| P/E (ttm): | N/A |
| EPS (ttm): | -1.13 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ChemoCentryx to Host Analyst DayGlobeNewswire(Wed, May 15)
- Wider-than-Expected Loss at ChemoCentryxZacks(Tue, May 14)
- CHEMOCENTRYX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibiEDGAR Online(Tue, May 14)
- CHEMOCENTRYX, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Tue, May 14)
- Edgen Group's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Mon, May 13)
- ChemoCentryx Announces Financial Results for the Quarter Ended March 31, 2013GlobeNewswire(Mon, May 13)
- Q1 2013 ChemoCentryx Inc Earnings Release - After Market CloseCCBN(Mon, May 13)
- Short Interest In ChemoCentryx Plummets 66%at TheStreet(Fri, May 10)
- Upcoming Catalysts Could Push ChemoCentryx To Double In 2013at Seeking Alpha(Fri, May 10)
- ChemoCentryx, Inc. to Hold First Quarter 2013 Financial Results Conference Call on Monday, May 13, 2013GlobeNewswire(Thu, May 2)
- ChemoCentryx to Present at Bank of America Merrill Lynch Healthcare ConferenceGlobeNewswire(Thu, May 2)
- ChemoCentryx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Over-Allotment OptionGlobeNewswire(Mon, Apr 22)
- CHEMOCENTRYX, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Wed, Apr 17)
- ChemoCentryx 5M share Secondary priced at $12.00theflyonthewall.com(Wed, Apr 17)
- ChemoCentryx Announces Pricing of Follow-On OfferingGlobeNewswire(Tue, Apr 16)
Press Releases
- ChemoCentryx to Host Analyst DayGlobeNewswire(Wed, May 15)
- ChemoCentryx Announces Financial Results for the Quarter Ended March 31, 2013GlobeNewswire(Mon, May 13)
- ChemoCentryx, Inc. to Hold First Quarter 2013 Financial Results Conference Call on Monday, May 13, 2013GlobeNewswire(Thu, May 2)
Reports
- ValuEngine Industry Report for Medical-drugsValuEngine, Inc.(May 17)
- ValuEngine Detailed Valuation Report for CCXIValuEngine, Inc.(May 16)
- CCXI - ChemoCentryx Inc - Rated a Hold - Company Analysis and ASR Ranking ReportAlpha Street Research(May 13)